Ricerca Biosciences, LLC And The Bicoll Group Enter Significant Collaboration Agreement

Concord, OH, Munich, Germany and Shanghai, P.R. China – Ricerca Biosciences, LLC and the Bicoll Group today announced the signing of a collaboration agreement. The agreement builds on a long-term relationship between the two companies.

Ricerca and Bicoll will combine their strengths in MedChem Services to offer innovative solutions that streamline drug discovery and development. With Ricerca's network of business development representatives throughout the United States, a close interaction to clients can be secured. Additionally, Ricerca will leverage Bicoll's medicinal chemistry and atural product chemistry technology for drug discovery to North American clients.

"We believe that the access to Bicoll's unique natural product chemistry technology as well as its competence in supportive reporting and IP protection will further strengthen our broad portfolio as a successful solution provider for product and process development and testing services," commented Thomas Bradshaw, Chief Executive Officer of Ricerca. "Bicoll's strong and reliable MedChem Services, conducted in China, will allow us to provide our clients with additional valuable support in drug discovery."

"Joining forces, Bicoll and Ricerca will be able to provide high medicinal, natural product, and custom synthetic chemistry services with a competitive price range to their clients," stated Dr. Kai Lamottke, General Manager of Bicoll (Shanghai) Co. Ltd. "As a state-of-the-art R&D company for high-tech natural product chemistry and drug discovery, the Bicoll Group has experienced an intensive growth spurt over the past few years – with the strong marketing partnership of Ricerca within North America we will now be able to provide our services together not only to European pharmaceutical customers, but to clients worldwide."

SOURCE: Ricerca Biosciences, LLC and Bicoll Group